These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3541490

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The onset of CML in blastic crisis: molecular features.
    Gregorini A, Filippetti A, Luchetti F, Walker A, Lillington DM, Papa S, Valentini M.
    J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM, Kantarjian HM, Talpaz M, O'Brien S, Cork A, Estey E, Pierce S, Keating M.
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu.
    Eksp Onkol; 1984 Jan; 6(5):53-5. PubMed ID: 6239771
    [Abstract] [Full Text] [Related]

  • 28. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
    López-Karpovitch X, Cárdenas R, Piedras J.
    Rev Invest Clin; 1997 Jan; 49(1):31-6. PubMed ID: 9229753
    [Abstract] [Full Text] [Related]

  • 29. [A "primitive" variant of the blast crisis in chronic myeloleukemia].
    Baryshnikov AIu, Turkina AG, Moiseenkova IN, Frolova EA, Sediakhina NP, Diagileva OA, Khoroshko ND, Mokeeva RA.
    Ter Arkh; 1995 Jan; 67(7):22-5. PubMed ID: 7482298
    [Abstract] [Full Text] [Related]

  • 30. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG, Sagawa K, Menon M, Minowada J.
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
    Kawakami K, Kiyosaki M, Amaya H, Nakamaki T, Hino K, Tomoyasu S.
    Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
    [Abstract] [Full Text] [Related]

  • 38. Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
    Oh SH, Park TS, Kim HR, Lee JY, Kim JH, Shin JH, Lee JN.
    Leuk Res; 2009 Nov; 33(11):e195-8. PubMed ID: 19446879
    [Abstract] [Full Text] [Related]

  • 39. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
    Morse EE, Gaffney J, Donskoy E, Pisciotto P, Altman A, Quinn J, Goldschneider I.
    Ann Clin Lab Sci; 1983 Nov; 13(2):128-32. PubMed ID: 6344744
    [Abstract] [Full Text] [Related]

  • 40. [Lymphoid blast crisis in chronic myelogenous leukemia].
    Ranft K.
    Dtsch Med Wochenschr; 1984 Jan 06; 109(1):20-3. PubMed ID: 6581956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.